AH 7921 is an analytical reference material categorized as an opioid. Also, It is an analgesic with high addictive liability in animal models. Furthermore, Order AH-7921 online is regulated as a Schedule I compound in the United States. Nevertheless, This product is intended for research and forensic applications. Look no further than us to Purchase AH 7921 Online.
Furthermore, The drug is considered a new psychoactive substance (NPS) in which it is synthetically created in laboratories to mimic that of controlled substances. Also, The substance has also been sold on the internet since 2012 as a “research chemical”. In addition, When sold online it may be called the alternative name Doxylam, not to be confused with doxylamine. Moreover, AH-7921 has never progressed to clinical trials. However, The DEA is not aware of any medical usage in the United States, and has not insisted the Health and Human Services department (HHS) to conduct any medical research of the substance uses.
Although AH-7921 was extensively studied in vitro and in animals, though not in humans, by the developing company, it was never sold commercially for medical use. Also, In 2013, AH-7921 was discovered to have been used as an active ingredient in “synthetic cannabis” products in Japan. Furthermore, In October 2015, two horses (Bossmon and Literata)
trained by owner-trainer Roy Sedlacek tested positive for AH-7921 at Belmont Park racetrack. However, Norway and Iceland use this substance as an analytical reference standard in which it can be ordered online from chemical suppliers; however, labels are required to state that it is not for human consumption thus conforming to the law.
In addition, Within ten months from 2013 – 2014, there have been serious fatalities reported from this drug from four different countries. The first fatality was a 19-year-old male who had a 3.9 mg/L AH-7921 concentration of heart blood leading medical examiners to confirm the death was an opioid intoxication. In another case, a 22-year-old woman was found dead with a femoral blood to AH-7921 concentration of 450µg/L. A 2018 review of published case reports found a total of 14 cases, of which 13 resulted in death. Moreover, The oral route of administration was reported in two cases, and most cases
reported use of concomitant pharmaceutical agents. Furthermore, Postmortem autopsies found that pulmonary edema was the most common finding, with nine of the cases having heavier lungs. Overall, fatalities occurred with low and high
concentrations of AH-7921 in femoral blood.
Showing the single result